Andrew P. Boright
Impact in
- Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders
- Hematology top 5%
- Blood groups and transfusion
Papers in
-
- Ubiquitin and proteasome pathways 2
-
- Paraoxonase enzyme and polymorphisms 2
- Co-authors
- Stephen W. Scherer (8 shared papers)Andrew D. Paterson (7 shared papers)Shelley B. Bull (5 shared papers)Lei Sun (4 shared papers)Lap‐Chee Tsui (2 shared papers)S. Mohsen Hosseini (3 shared papers)Lucia Mirea (2 shared papers)Jeffrey R. Lee (1 shared paper)
- Journals
- Diabetes (3 papers)Atherosclerosis (2 papers)Human Genetics (2 papers)The American Journal of Human Genetics (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- CanadaUnited StatesAustria
In The Last Decade
Andrew P. Boright
17 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Clinical Biochemistry 362
- Hematology 141
- Biochemistry 74
- Ophthalmology 70
- Genetics 86
Countries citing papers authored by Andrew P. Boright
This map shows the geographic impact of Andrew P. Boright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Boright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Boright more than expected).
Fields of papers citing papers by Andrew P. Boright
This network shows the impact of papers produced by Andrew P. Boright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Boright. The network helps show where Andrew P. Boright may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew P. Boright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 327 | |
| 2 | 2009 | 157 | |
| 3 | 2001 | 130 | |
| 4 | 1999 | 108 | |
| 5 | 2009 | 82 | |
| 6 | 2007 | 81 | |
| 7 | 2005 | 74 | |
| 8 | 1998 | 58 | |
| 9 | 1998 | 50 | |
| 10 | 2014 | 48 | |
| 11 | Prolidase deficiency: biochemical classification of alleles. | 1989 | 33 |
| 12 | 1998 | 31 | |
| 13 | 2006 | 13 | |
| 14 | 2009 | 12 | |
| 15 | 2003 | 7 | |
| 16 | F5 Q506 mutation and the low prevalence of cardiovascular disease in Canadian Inuit. | 1998 | 7 |
| 17 | 2003 | 1 | |
| 18 | 1984 | 1 |
About Andrew P. Boright
Andrew P. Boright is a scholar working on Molecular Biology, Clinical Biochemistry, Surgery, Nephrology and Genetics, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Paraoxonase enzyme and polymorphisms (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Retinal Diseases and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Folate and B Vitamins Research (1 paper) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Clinical Biochemistry (362 citations), Hematology (141 citations), Biochemistry (74 citations), Ophthalmology (70 citations) and Genetics (86 citations). Andrew P. Boright has collaborated with scholars based in Canada, United States and Austria. Frequent co-authors include Stephen W. Scherer, Andrew D. Paterson, Shelley B. Bull, Lei Sun, Lap‐Chee Tsui, S. Mohsen Hosseini, Lucia Mirea, Jeffrey R. Lee, Michael A. Crackower and Keiko Kobayashi. Their work appears in journals such as Diabetes, Atherosclerosis, Human Genetics, The American Journal of Human Genetics and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.